世界の野兎病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Tularaemia Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4988
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、野兎病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ARD-3150、シプロフロキサシン塩酸塩、EV-035、NDBR-101、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・野兎病治療の市場動向
・企業の競争状況、市場シェア
・野兎病治療の種類別市場規模と予測2016-2027（ARD-3150、シプロフロキサシン塩酸塩、EV-035、NDBR-101、その他）
・野兎病治療の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・野兎病治療の北米市場規模2016-2027（アメリカ、カナダ）
・野兎病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・野兎病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・野兎病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・野兎病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Aradigm Corp、Arno Therapeutics Inc、DynPort Vaccine Company LLC、Emergent BioSolutions Inc、EpiVax Inc、Grifols SA、Merck & Co Inc、Tetraphase Pharmaceuticals Inc）
・結論

Market Analysis and Insights: Global Tularaemia Treatment Market
The global Tularaemia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tularaemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tularaemia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tularaemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tularaemia Treatment market.

Global Tularaemia Treatment Scope and Market Size
Tularaemia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tularaemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
ARD-3150
Ciprofloxacin Hydrochloride
EV-035
NDBR-101
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Aradigm Corp
Arno Therapeutics Inc
DynPort Vaccine Company LLC
Emergent BioSolutions Inc
EpiVax Inc
Grifols SA
Merck & Co Inc
Tetraphase Pharmaceuticals Inc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tularaemia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ARD-3150
1.2.3 Ciprofloxacin Hydrochloride
1.2.4 EV-035
1.2.5 NDBR-101
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tularaemia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tularaemia Treatment Market Perspective (2016-2027)
2.2 Tularaemia Treatment Growth Trends by Regions
2.2.1 Tularaemia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tularaemia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Tularaemia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Tularaemia Treatment Industry Dynamic
2.3.1 Tularaemia Treatment Market Trends
2.3.2 Tularaemia Treatment Market Drivers
2.3.3 Tularaemia Treatment Market Challenges
2.3.4 Tularaemia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tularaemia Treatment Players by Revenue
3.1.1 Global Top Tularaemia Treatment Players by Revenue (2016-2021)
3.1.2 Global Tularaemia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Tularaemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tularaemia Treatment Revenue
3.4 Global Tularaemia Treatment Market Concentration Ratio
3.4.1 Global Tularaemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tularaemia Treatment Revenue in 2020
3.5 Tularaemia Treatment Key Players Head office and Area Served
3.6 Key Players Tularaemia Treatment Product Solution and Service
3.7 Date of Enter into Tularaemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tularaemia Treatment Breakdown Data by Type
4.1 Global Tularaemia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Tularaemia Treatment Forecasted Market Size by Type (2022-2027)

5 Tularaemia Treatment Breakdown Data by Application
5.1 Global Tularaemia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Tularaemia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tularaemia Treatment Market Size (2016-2027)
6.2 North America Tularaemia Treatment Market Size by Type
6.2.1 North America Tularaemia Treatment Market Size by Type (2016-2021)
6.2.2 North America Tularaemia Treatment Market Size by Type (2022-2027)
6.2.3 North America Tularaemia Treatment Market Size by Type (2016-2027)
6.3 North America Tularaemia Treatment Market Size by Application
6.3.1 North America Tularaemia Treatment Market Size by Application (2016-2021)
6.3.2 North America Tularaemia Treatment Market Size by Application (2022-2027)
6.3.3 North America Tularaemia Treatment Market Size by Application (2016-2027)
6.4 North America Tularaemia Treatment Market Size by Country
6.4.1 North America Tularaemia Treatment Market Size by Country (2016-2021)
6.4.2 North America Tularaemia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Tularaemia Treatment Market Size (2016-2027)
7.2 Europe Tularaemia Treatment Market Size by Type
7.2.1 Europe Tularaemia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Tularaemia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Tularaemia Treatment Market Size by Type (2016-2027)
7.3 Europe Tularaemia Treatment Market Size by Application
7.3.1 Europe Tularaemia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Tularaemia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Tularaemia Treatment Market Size by Application (2016-2027)
7.4 Europe Tularaemia Treatment Market Size by Country
7.4.1 Europe Tularaemia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Tularaemia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tularaemia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Tularaemia Treatment Market Size by Type
8.2.1 Asia-Pacific Tularaemia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tularaemia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tularaemia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Tularaemia Treatment Market Size by Application
8.3.1 Asia-Pacific Tularaemia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tularaemia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tularaemia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Tularaemia Treatment Market Size by Region
8.4.1 Asia-Pacific Tularaemia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tularaemia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tularaemia Treatment Market Size (2016-2027)
9.2 Latin America Tularaemia Treatment Market Size by Type
9.2.1 Latin America Tularaemia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Tularaemia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Tularaemia Treatment Market Size by Type (2016-2027)
9.3 Latin America Tularaemia Treatment Market Size by Application
9.3.1 Latin America Tularaemia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Tularaemia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Tularaemia Treatment Market Size by Application (2016-2027)
9.4 Latin America Tularaemia Treatment Market Size by Country
9.4.1 Latin America Tularaemia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Tularaemia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tularaemia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Tularaemia Treatment Market Size by Type
10.2.1 Middle East & Africa Tularaemia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tularaemia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tularaemia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Tularaemia Treatment Market Size by Application
10.3.1 Middle East & Africa Tularaemia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tularaemia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tularaemia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Tularaemia Treatment Market Size by Country
10.4.1 Middle East & Africa Tularaemia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tularaemia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Aradigm Corp
11.1.1 Aradigm Corp Company Details
11.1.2 Aradigm Corp Business Overview
11.1.3 Aradigm Corp Tularaemia Treatment Introduction
11.1.4 Aradigm Corp Revenue in Tularaemia Treatment Business (2016-2021)
11.1.5 Aradigm Corp Recent Development
11.2 Arno Therapeutics Inc
11.2.1 Arno Therapeutics Inc Company Details
11.2.2 Arno Therapeutics Inc Business Overview
11.2.3 Arno Therapeutics Inc Tularaemia Treatment Introduction
11.2.4 Arno Therapeutics Inc Revenue in Tularaemia Treatment Business (2016-2021)
11.2.5 Arno Therapeutics Inc Recent Development
11.3 DynPort Vaccine Company LLC
11.3.1 DynPort Vaccine Company LLC Company Details
11.3.2 DynPort Vaccine Company LLC Business Overview
11.3.3 DynPort Vaccine Company LLC Tularaemia Treatment Introduction
11.3.4 DynPort Vaccine Company LLC Revenue in Tularaemia Treatment Business (2016-2021)
11.3.5 DynPort Vaccine Company LLC Recent Development
11.4 Emergent BioSolutions Inc
11.4.1 Emergent BioSolutions Inc Company Details
11.4.2 Emergent BioSolutions Inc Business Overview
11.4.3 Emergent BioSolutions Inc Tularaemia Treatment Introduction
11.4.4 Emergent BioSolutions Inc Revenue in Tularaemia Treatment Business (2016-2021)
11.4.5 Emergent BioSolutions Inc Recent Development
11.5 EpiVax Inc
11.5.1 EpiVax Inc Company Details
11.5.2 EpiVax Inc Business Overview
11.5.3 EpiVax Inc Tularaemia Treatment Introduction
11.5.4 EpiVax Inc Revenue in Tularaemia Treatment Business (2016-2021)
11.5.5 EpiVax Inc Recent Development
11.6 Grifols SA
11.6.1 Grifols SA Company Details
11.6.2 Grifols SA Business Overview
11.6.3 Grifols SA Tularaemia Treatment Introduction
11.6.4 Grifols SA Revenue in Tularaemia Treatment Business (2016-2021)
11.6.5 Grifols SA Recent Development
11.7 Merck & Co Inc
11.7.1 Merck & Co Inc Company Details
11.7.2 Merck & Co Inc Business Overview
11.7.3 Merck & Co Inc Tularaemia Treatment Introduction
11.7.4 Merck & Co Inc Revenue in Tularaemia Treatment Business (2016-2021)
11.7.5 Merck & Co Inc Recent Development
11.8 Tetraphase Pharmaceuticals Inc
11.8.1 Tetraphase Pharmaceuticals Inc Company Details
11.8.2 Tetraphase Pharmaceuticals Inc Business Overview
11.8.3 Tetraphase Pharmaceuticals Inc Tularaemia Treatment Introduction
11.8.4 Tetraphase Pharmaceuticals Inc Revenue in Tularaemia Treatment Business (2016-2021)
11.8.5 Tetraphase Pharmaceuticals Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Tularaemia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ARD-3150
Table 3. Key Players of Ciprofloxacin Hydrochloride
Table 4. Key Players of EV-035
Table 5. Key Players of NDBR-101
Table 6. Key Players of Others
Table 7. Global Tularaemia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Tularaemia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Tularaemia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Tularaemia Treatment Market Share by Regions (2016-2021)
Table 11. Global Tularaemia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Tularaemia Treatment Market Share by Regions (2022-2027)
Table 13. Tularaemia Treatment Market Trends
Table 14. Tularaemia Treatment Market Drivers
Table 15. Tularaemia Treatment Market Challenges
Table 16. Tularaemia Treatment Market Restraints
Table 17. Global Tularaemia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Tularaemia Treatment Market Share by Players (2016-2021)
Table 19. Global Top Tularaemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tularaemia Treatment as of 2020)
Table 20. Ranking of Global Top Tularaemia Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Tularaemia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Tularaemia Treatment Product Solution and Service
Table 24. Date of Enter into Tularaemia Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Tularaemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Tularaemia Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Tularaemia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Tularaemia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Tularaemia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Tularaemia Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Tularaemia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Tularaemia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Tularaemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Tularaemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Tularaemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Tularaemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Tularaemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Tularaemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Tularaemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Tularaemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Tularaemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Tularaemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Tularaemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Tularaemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Tularaemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Tularaemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Tularaemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Tularaemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Tularaemia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Tularaemia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Tularaemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Tularaemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Tularaemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Tularaemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Tularaemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Tularaemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Tularaemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Tularaemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Tularaemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Tularaemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Tularaemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Tularaemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Aradigm Corp Company Details
Table 65. Aradigm Corp Business Overview
Table 66. Aradigm Corp Tularaemia Treatment Product
Table 67. Aradigm Corp Revenue in Tularaemia Treatment Business (2016-2021) & (US$ Million)
Table 68. Aradigm Corp Recent Development
Table 69. Arno Therapeutics Inc Company Details
Table 70. Arno Therapeutics Inc Business Overview
Table 71. Arno Therapeutics Inc Tularaemia Treatment Product
Table 72. Arno Therapeutics Inc Revenue in Tularaemia Treatment Business (2016-2021) & (US$ Million)
Table 73. Arno Therapeutics Inc Recent Development
Table 74. DynPort Vaccine Company LLC Company Details
Table 75. DynPort Vaccine Company LLC Business Overview
Table 76. DynPort Vaccine Company LLC Tularaemia Treatment Product
Table 77. DynPort Vaccine Company LLC Revenue in Tularaemia Treatment Business (2016-2021) & (US$ Million)
Table 78. DynPort Vaccine Company LLC Recent Development
Table 79. Emergent BioSolutions Inc Company Details
Table 80. Emergent BioSolutions Inc Business Overview
Table 81. Emergent BioSolutions Inc Tularaemia Treatment Product
Table 82. Emergent BioSolutions Inc Revenue in Tularaemia Treatment Business (2016-2021) & (US$ Million)
Table 83. Emergent BioSolutions Inc Recent Development
Table 84. EpiVax Inc Company Details
Table 85. EpiVax Inc Business Overview
Table 86. EpiVax Inc Tularaemia Treatment Product
Table 87. EpiVax Inc Revenue in Tularaemia Treatment Business (2016-2021) & (US$ Million)
Table 88. EpiVax Inc Recent Development
Table 89. Grifols SA Company Details
Table 90. Grifols SA Business Overview
Table 91. Grifols SA Tularaemia Treatment Product
Table 92. Grifols SA Revenue in Tularaemia Treatment Business (2016-2021) & (US$ Million)
Table 93. Grifols SA Recent Development
Table 94. Merck & Co Inc Company Details
Table 95. Merck & Co Inc Business Overview
Table 96. Merck & Co Inc Tularaemia Treatment Product
Table 97. Merck & Co Inc Revenue in Tularaemia Treatment Business (2016-2021) & (US$ Million)
Table 98. Merck & Co Inc Recent Development
Table 99. Tetraphase Pharmaceuticals Inc Company Details
Table 100. Tetraphase Pharmaceuticals Inc Business Overview
Table 101. Tetraphase Pharmaceuticals Inc Revenue in Tularaemia Treatment Business (2016-2021) & (US$ Million)
Table 102. Tetraphase Pharmaceuticals Inc Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tularaemia Treatment Market Share by Type: 2020 VS 2027
Figure 2. ARD-3150 Features
Figure 3. Ciprofloxacin Hydrochloride Features
Figure 4. EV-035 Features
Figure 5. NDBR-101 Features
Figure 6. Others Features
Figure 7. Global Tularaemia Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Tularaemia Treatment Report Years Considered
Figure 12. Global Tularaemia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Tularaemia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Tularaemia Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Tularaemia Treatment Market Share by Regions (2022-2027)
Figure 16. Global Tularaemia Treatment Market Share by Players in 2020
Figure 17. Global Top Tularaemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tularaemia Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Tularaemia Treatment Revenue in 2020
Figure 19. Global Tularaemia Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Tularaemia Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Tularaemia Treatment Market Share by Type (2016-2027)
Figure 23. North America Tularaemia Treatment Market Share by Application (2016-2027)
Figure 24. North America Tularaemia Treatment Market Share by Country (2016-2027)
Figure 25. United States Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Tularaemia Treatment Market Share by Type (2016-2027)
Figure 29. Europe Tularaemia Treatment Market Share by Application (2016-2027)
Figure 30. Europe Tularaemia Treatment Market Share by Country (2016-2027)
Figure 31. Germany Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Tularaemia Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Tularaemia Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Tularaemia Treatment Market Share by Region (2016-2027)
Figure 41. China Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Tularaemia Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Tularaemia Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Tularaemia Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Tularaemia Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Tularaemia Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Tularaemia Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Tularaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Aradigm Corp Revenue Growth Rate in Tularaemia Treatment Business (2016-2021)
Figure 61. Arno Therapeutics Inc Revenue Growth Rate in Tularaemia Treatment Business (2016-2021)
Figure 62. DynPort Vaccine Company LLC Revenue Growth Rate in Tularaemia Treatment Business (2016-2021)
Figure 63. Emergent BioSolutions Inc Revenue Growth Rate in Tularaemia Treatment Business (2016-2021)
Figure 64. EpiVax Inc Revenue Growth Rate in Tularaemia Treatment Business (2016-2021)
Figure 65. Grifols SA Revenue Growth Rate in Tularaemia Treatment Business (2016-2021)
Figure 66. Merck & Co Inc Revenue Growth Rate in Tularaemia Treatment Business (2016-2021)
Figure 67. Tetraphase Pharmaceuticals Inc Revenue Growth Rate in Tularaemia Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界の多汗症治療市場規模・現状・予測（2021年-2027年）

Global Hyperhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4337 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、外科治療、理学療法、その他）、用途別市場規模（病院、皮膚科、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の睡眠麻痺治療市場規模・現状・予測（2021年-2027年）

Global Sleep Paralysis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4872 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、睡眠麻痺治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（覚醒剤、選択的セロトニン再取り込み阻害薬（SSRI）、三環系抗うつ薬、オキシベートナトリウム）、用途別市場規模（病院、家庭、介護センター、そ...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の非薬物式うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Free Depression Treatment Market The global Drug Free Depression Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界の家族性大腸腺腫症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Familial Adenomatous Polyposis Treatment Market The global Familial Adenomatous Polyposis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
世界の血管損傷治療市場規模・現状・予測（2021年-2027年） The term "vascular trauma" refers to injury to a blood vessel—an artery, which carries blood to an extremity or an organ, or a vein, which returns blood to the heart. Vascular Surgeons categorize these injuries by the type of trauma that caused them: blunt or penetrating injury. Market Analysis and …
世界の天然痘治療市場規模・現状・予測（2021年-2027年） Smallpox was an infectious disease caused by one of two virus variants, Variola major and Variola minor. Vaccine development and manufacturing process requires tremendous effort and expertise upstream as well as downstream. Hence governments are focusing on contract manufacturing practices to develo…
世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年） Choledocholithiasis is a condition wherein gall stones are found in the common bile duct instead of the gall bladder. Market Analysis and Insights: Global Choledocholithiasis Treatment Market The global Choledocholithiasis Treatment market size is projected to reach US$ XX million by 2027, from US$ …